Working… Menu
Trial record 71 of 242 for:    furosemide

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00512811
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : August 8, 2007
Information provided by:
Baqiyatallah Medical Sciences University

Brief Summary:
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Condition or disease Intervention/treatment Phase
Bronchiolitis Drug: furosemide Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. effect of furosemid inhalation on dyspnea

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   32 Years to 83 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00512811

Layout table for location information
Iran, Islamic Republic of
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Layout table for investigator information
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran

Layout table for additonal information Identifier: NCT00512811     History of Changes
Other Study ID Numbers: 121a25
First Posted: August 8, 2007    Key Record Dates
Last Update Posted: August 8, 2007
Last Verified: August 2007
Keywords provided by Baqiyatallah Medical Sciences University:
mustard gas
sulfur mustard
Additional relevant MeSH terms:
Layout table for MeSH terms
Respiratory Aspiration
Respiration Disorders
Respiratory Tract Diseases
Pathologic Processes
Bronchial Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections
Signs and Symptoms, Respiratory
Signs and Symptoms
Mustard Gas
Natriuretic Agents
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Alkylating Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents
Dermatologic Agents